Startseite Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges

  • Nikoleta Poumpouridou und Christos Kroupis EMAIL logo
Veröffentlicht/Copyright: 23. Dezember 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Despite the initial enthusiasm following the discovery of the association of BRCA germline mutations with hereditary breast and/or ovarian cancer, in many families affected by the syndrome no pathogenic mutations were detected in the two genes, although exhaustively searched. Many other genes have also been implicated due to their role in the same pathway of DNA repair where the BRCA1/2 genes are involved: homologous recombination (HR). Among them, PALB2 clearly emerges as the third breast cancer susceptibility gene. Its mutations have been detected in most populations investigated so far, albeit rarely: in 1%–4% of families negative for BRCA mutations, with either partial or complete penetrance. In some populations, PALB2 recurrent mutations have been identified and the estimated hazard risks are comparable to those of BRCA mutations. Since new effective targeted therapeutic options are becoming available (“synthetic lethality” with novel PARP inhibitors, etc.) that are applicable to all those patients with a defect in HR pathway, it is imperative to detect all these candidate patients. Data obtained from laboratory tests in the tumor (simple immunohistochemistry, gene expression analysis, etc.) can assist in the recognition of a specific pattern (BRCA1ness, HRless) so that even patients that look “sporadic” could benefit from these targeted therapies. Therefore, a genetic analysis algorithm is proposed, although with the advent of Next Generation Sequencing it is predicted that in the future most germline genetic alterations and also somatic or epigenetic events in the tumor of these genes will be detected.


Corresponding author: Christos Kroupis, MSc, PhD, Assistant Professor of Clinical Biochemistry and Molecular Diagnostics, Department of Clinical Biochemistry, Attikon University Hospital, University of Athens Medical School, 1 Rimini Street, Haidari 12462, GreecePhone: +30 210 5831919, Fax: +30 210 6547748

Received: 2011-9-6
Accepted: 2011-11-30
Published Online: 2011-12-23
Published in Print: 2012-03-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Editorials
  2. An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports
  3. Cancer diagnosis: from dogs to DNA or from DNA to dogs?
  4. The never-ending search of an acceptable compromise for pancreatic lipase standardisation
  5. Review
  6. Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges
  7. Mini Review
  8. Canine olfactory detection of cancer versus laboratory testing: myth or opportunity?
  9. Genetics and Molecular Diagnostics
  10. SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians
  11. Elevated plasma matrix metalloproteinase-9 protein and its gene polymorphism in patients with community-acquired pneumonia
  12. General Clinical Chemistry and Laboratory Medicine
  13. Minimum analytical quality specifications of inter-laboratory comparisons: agreement among Spanish EQAP organizers
  14. Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement
  15. Speed of sample transportation by a pneumatic tube system can influence the degree of hemolysis
  16. 1,2-Dioleoylglycerol method for pancreatic lipase catalytic activity in serum
  17. Serum lactate dehydrogenase levels significantly correlate with radiological extent of disease and spirometric values in patients with silicosis due to denim sandblasting
  18. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis
  19. The relationship between antinuclear antibody data and antibodies against extractable nuclear antigens in a large laboratory cohort
  20. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis
  21. Trueness in the measurement of haemoglobin: consensus or reference method?
  22. Soluble transcobalamin receptor, sCD320, is present in human serum and relates to serum cobalamin – establishment and validation of an ELISA
  23. An on-line solid phase extraction procedure for the routine quantification of caspofungin by liquid chromatography-tandem mass spectrometry
  24. Effects of subcutaneous low molecular weight heparin and intravenous unfractionated heparin on serum S100 concentrations in patients with cerebrovascular diseases
  25. Urinary 8-hydroxy-2′-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer’s disease
  26. A HPLC-MS method to detect and quantify guanfacine in urine
  27. Collection and storage requirements for urinary kidney injury molecule-1 (KIM-1) measurements in humans
  28. Kidney stones in a Mediterranean population from the south of Spain
  29. Reference Values and Biological Variations
  30. First trimester biochemistry at different maternal ages
  31. Age- and gender-related alteration in plasma advanced oxidation protein products (AOPP) and glycosaminoglycan (GAG) concentrations in physiological ageing
  32. Cancer Diagnostics
  33. Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients
  34. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics
  35. Letters to the Editor
  36. Aberrant results observed with four immuno-assays for total and free prostate-specific antigen (PSA) determination: a case-report
  37. Assay-dependent abnormalities in measurements of prostate-specific antigen in serum: an occasional occurrence, but of clinical significance
  38. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain κ and λ to polyclonal antibody-based assays and immunofixation electrophoresis
  39. Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses
  40. Leptin levels in exhaled breath condensate from asthmatic children: a pilot study
  41. Masthead
  42. Masthead
Heruntergeladen am 11.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2011-0840/html
Button zum nach oben scrollen